NMR-based metabolomics to determine acute inhalation effects of nano- and fine-sized ZnO particles in the rat lung

Nanotoxicology

Volumn 10, Issue 7, 2016, Pages 924-934

  Lee, Sheng Han ^a   Wang, Ting Yi ^a   Hong, Jia Huei ^a   Cheng, Tsun Jen ^a   Lin, Ching Yu ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Fine particles; metabolomics; nano particles; respiratory toxicity; zinc oxide

Indexed keywords

ACETIC ACID; ASCORBIC ACID; FORMIC ACID; GLUCOSE; GLYCEROPHOSPHORYLCHOLINE; GLYCINE; ISOLEUCINE; PHOSPHORYLCHOLINE; TAURINE; TRIMETHYLAMINE OXIDE; VALINE; ZINC OXIDE; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CONTROLLED STUDY; DNA DAMAGE; DOSE RESPONSE; DRUG MEGADOSE; ENERGY METABOLISM; INHALATION; LUNG DISEASE; LUNG PARENCHYMA; MALE; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SPRAGUE DAWLEY RAT; TREND STUDY; ADVERSE EFFECTS; ANIMAL; CHEMISTRY; DRUG EFFECTS; EXPOSURE; HUMAN; LUNG; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; HUMANS; INHALATION EXPOSURE; LUNG; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; ZINC OXIDE;

EID: 84961208436     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2016.1144825     Document Type: Article

References (57)

1. M.A.Banks, D.W.Porter, W.G.Martin, V.Castranova 1991. Ozone-induced lipid peroxidation and membrane leakage in isolated rat alveolar macrophages: protective effects of taurine. J Nutr Biochem 2:308–13.
2. W.S.Beckett, D.F.Chalupa, A.Pauly-Brown, D.M.Speers, J.C.Stewart, M.W.Frampton, et al. 2005. Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: a human inhalation study. Am J Respir Crit Care Med 171:1129–35.
3. Y.Benjamini, Y.Hochberg 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 57:289–300.
4. S.K.Biswas, I.Rahman 2009. Environmental toxicity, redox signaling and lung inflammation: the role of glutathione. Mol Aspects Med 30:60–76.
5. E.G.Bligh, W.J.Dyer 1959. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–17.
6. Q.Bu, G.Yan, P.Deng, F.Peng, H.Lin, Y.Xu, et al. 2010. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration. Nanotechnology 21:125105.
7. J.Carrola, C.M.Rocha, A.S.Barros, A.M.Gil, B.J.Goodfellow, I.M.Carreira, et al. 2011. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J Proteome Res 10:221–30.
8. F.R.Cassee, H.Muijser, E.Duistermaat, J.J.Freijer, K.B.Geerse, J.C.Marijnissen, et al. 2002. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model. Arch Toxicol 76:277–86.
9. W.S.Cho, R.Duffin, C.A.Poland, A.Duschl, G.J.Oostingh, W.Macnee, et al. 2012. Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology 6:22–35.
10. W.S.Cho, R.Duffin, C.A.Poland, S.E.Howie, W.Macnee, M.Bradley, et al. 2010. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Perspect 118:1699–706.
11. R.B.Conolly, W.K.Lutz 2004. Nonmonotonic dose-response relationships: mechanistic basis, kinetic modeling, and implications for risk assessment. Toxicol Sci 77:151–7.
12. J.P.Fabisiak, M.Medvedovic, D.C.Alexander, J.E.Mcdunn, V.J.Concel, K.Bein, et al. 2011. Integrative metabolome and transcriptome profiling reveals discordant energetic stress between mouse strains with differential sensitivity to acrolein-induced acute lung injury. Mol Nutr Food Res 55:1423–34.
13. J.M.Fine, T.Gordon, L.C.Chen, P.Kinney, G.Falcone, W.S.Beckett 1997. Metal fume fever: characterization of clinical and plasma IL-6 responses in controlled human exposures to zinc oxide fume at and below the threshold limit value. J Occup Environ Med 39:722–6.
14. A.Gojova, B.Guo, R.S.Kota, J.C.Rutledge, I.M.Kennedy, A.I.Barakat 2007. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ Health Perspect 115:403–9.
15. T.Gordon, J.M.Fine 1993. Metal fume fever. Occup Med 8:505–17.
16. J.L.Griffin, A.W.Nicholls 2006. Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders. Pharmacogenomics 7:1095–107.
17. M.Guérard, M.Baum, A.Bitsch, G.Eisenbrand, A.Elhajouji, B.Epe, et al. 2015. Assessment of mechanisms driving non-linear dose-response relationships in genotoxicity testing. – relationships genotoxicity. Mutat Res Rev Mutat Res 763:181–201.
18. H.Gurer, H.Ozgunes, E.Saygin, N.Ercal 2001. Antioxidant effect of taurine against lead-induced oxidative stress. Arch Environ Contam Toxicol 41:397–402.
19. M.Ho, K.Y.Wu, H.M.Chein, L.C.Chen, T.J.Cheng 2011. Pulmonary toxicity of inhaled nanoscale and fine zinc oxide particles: mass and surface area as an exposure metric. Inhal Toxicol 23:947–56.
20. J.H.Hong, W.C.Lee, Y.M.Hsu, H.J.Liang, C.H.Wan, C.L.Chien, et al. 2014. Characterization of the biochemical effects of naphthalene on the mouse respiratory system using NMR-based metabolomics. J Appl Toxicol 34:1379–88.
21. J.Z.Hu, D.N.Rommereim, K.R.Minard, A.Woodstock, B.J.Harrer, R.A.Wind, et al. 2008. Metabolomics in lung inflammation:a high-resolution (1)h NMR study of mice exposedto silica dust. Toxicol Mech Methods 18:385–98.
22. L.Jiang, B.I.Gulanski, H.M.De Feyter, S.A.Weinzimer, B.Pittman, E.Guidone, et al. 2013. Increased brain uptake and oxidation of acetate in heavy drinkers. J Clin Invest 123:1605–14.
23. G.S.Kang, P.A.Gillespie, A.Gunnison, H.Rengifo, J.Koberstein, L.C.Chen 2011. Comparative pulmonary toxicity of inhaled nickel nanoparticles; role of deposited dose and solubility. Inhal Toxicol 23:95–103.
24. W.G.Kuschner, A.Dalessandro, H.F.Wong, P.D.Blanc 1997. Early pulmonary cytokine responses to zinc oxide fume inhalation. Environ Res 75:7–11.
25. R.Lei, C.Wu, B.Yang, H.Ma, C.Shi, Q.Wang, et al. 2008. Integrated metabolomic analysis of the nano-sized copper particle-induced hepatotoxicity and nephrotoxicity in rats: a rapid in vivo screening method for nanotoxicity. Toxicol Appl Pharmacol 232:292–301.
26. C.Y.Lin, M.R.Viant, R.S.Tjeerdema 2006. Metabolomics: methodologies and applications in the environmental sciences. J Pestic Sci 31:245–51.
27. C.Y.Lin, H.Wu, R.Tjeerdema, M.Viant 2007. Evaluation of metabolite extraction strategies from tissue samples using NMR metabolomics. Metabolomics 3:55–67.
28. C.Y.Lin, B.S.Anderson, B.M.Phillips, A.C.Peng, S.Clark, J.Voorhees, et al. 2009a. Characterization of the metabolic actions of crude versus dispersed oil in salmon smolts via NMR-based metabolomics. Aquat Toxicol 95:230–8.
29. C.Y.Lin, P.H.Hung, C.A.Vandevoort, M.G.Miller 2009b. 1H NMR to investigate metabolism and energy supply in rhesus macaque sperm. Reprod Toxicol 28:75–80.
30. W.S.Lin, Y.Xu, C.C.Huang, Y.F.Ma, K.B.Shannon, D.R.Chen, et al. 2009c. Toxicity of nano- and micro-sized ZnO particles in human lung epithelial cells. J Nanopart Res 11:25–39.
31. Z.Y.Lin, P.B.Xu, S.K.Yan, H.B.Meng, G.J.Yang, W.X.Dai, et al. 2009d. A metabonomic approach to early prognostic evaluation of experimental sepsis by (1)H NMR and pattern recognition. NMR Biomed 22:601–8.
32. C.Ludwig, M.R.Viant 2010. Two-dimensional J-resolved NMR spectroscopy: review of a key methodology in the metabolomics toolbox. Phytochem Anal 21:22–32.
33. A.Meister 1994. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem 269:9397–400.
34. J.K.Nicholson, P.J.D.Foxall, M.Spraul, R.D.Farrant, J.C.Lindon 1995. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem 67:793–811.
35. G.Oberdorster, A.Maynard, K.Donaldson, V.Castranova, J.Fitzpatrick, K.Ausman, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8.
36. M.Oostendorp, U.F.H.Engelke, M.P.Willemsen, R.A.Wevers 2006. Diagnosing inborn errors of lipid metabolism with proton nuclear magnetic resonance spectroscopy. Clin Chem 52:1395–405.
37. X.Ouyang, Y.Dai, J.L.Wen, L.X.Wang 2011. ¹H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus. Lupus 20:1411–20.
38. R.Plumb, J.Granger, C.Stumpf, I.D.Wilson, J.A.Evans, E.M.Lenz 2003. Metabonomic analysis of mouse urine by liquid-chromatography-time of flight mass spectrometry (LC-TOFMS): detection of strain, diurnal and gender differences. Analyst 128:819–23.
39. I.Pujalte, I.Passagne, B.Brouillaud, M.Treguer, E.Durand, C.Ohayon-Courtes, et al. 2011. Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells. Part Fibre Toxicol 8:10.
40. R.C.Rose, A.M.Bode 1993. Biology of free radical scavengers: an evaluation of ascorbate. FASEB J 7:1135–42.
41. C.M.Sayes, K.L.Reed, D.B.Warheit 2007. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 97:163–80.
42. S.W.Schaffer, J.Azuma, M.Mozaffari 2009. Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 87:91–9.
43. G.B.Schuller-Levis, E.Park 2003. Taurine: new implications for an old amino acid. FEMS Microbiol Lett 226:195–202.
44. N.J.Serkova, Z.Van Rheen, M.Tobias, J.E.Pitzer, J.E.Wilkinson, K.A.Stringer 2008. Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 295:L152–61.
45. C.H.Tang, P.N.Tsao, C.Y.Chen, M.S.Shiao, W.H.Wang, C.Y.Lin 2011. Glycerophosphocholine molecular species profiling in the biological tissue using UPLC/MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 879:2095–106.
46. G.Van Meer, D.R.Voelker, G.W.Feigenson 2008. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9:112–24.
47. M.R.Viant 2003. Improved methods for the acquisition and interpretation of NMR metabolomic data. Biochem Biophys Res Commun 310:943–8.
48. Z.L.Wang 2008. Splendid one-dimensional nanostructures of zinc oxide: a new nanomaterial family for nanotechnology. ACS Nano 2:1987–92.
49. D.B.Warheit, C.M.Sayes, K.L.Reed 2009. Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures? Environ Sci Technol 43:7939–45.
50. M.R.Wenk 2010. Lipidomics: new tools and applications. Cell 143:888–95.
51. J.Westerhuis, H.J.Hoefsloot, S.Smit, D.Vis, A.Smilde, E.J.Velzen, et al. 2008. Assessment of PLSDA cross validation. Metabolomics 4:81–9.
52. W.Wu, J.M.Samet, D.B.Peden, P.A.Bromberg 2010. Phosphorylation of p65 is required for zinc oxide nanoparticle-induced interleukin 8 expression in human bronchial epithelial cells. Environ Health Perspect 118:982–7.
53. T.Xia, M.Kovochich, M.Liong, L.Maedler, B.Gilbert, H.Shi, et al. 2008. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2:2121–34.
54. G.Yan, Y.Huang, Q.Bu, L.Lv, P.Deng, J.Zhou, et al. 2012. Zinc oxide nanoparticles cause nephrotoxicity and kidney metabolism alterations in rats. J Environ Sci Health A Tox Hazard Subst Environ Eng 47:577–88.
55. G.Zhai, R.Wang-Sattler, D.J.Hart, N.K.Arden, A.J.Hakim, T.Illig, et al. 2010. Serum branched-chain amino acid to histidine ratio: a novel metabolomic biomarker of knee osteoarthritis. Ann Rheum Dis 69:1227–31.
56. S.C.Zhang, G.N.Gowda, V.Asiago, N.Shanaiah, C.Barbas, D.Raftery 2008. Correlative and quantitative 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats. Anal Biochem 383:76–84.
57. J.Zhao, L.Xu, T.Zhang, G.Ren, Z.Yang 2009. Influences of nanoparticle zinc oxide on acutely isolated rat hippocampal CA3 pyramidal neurons. Neurotoxicology 30:220–30.